• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI Executive AssistantNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI Executive AssistantNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Helper
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees for your businessNEW
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form SC 13G/A filed by UnitedHealth Group Incorporated (Amendment)

    2/10/22 8:42:47 AM ET
    $UNH
    Medical Specialities
    Health Care
    Get the next $UNH alert in real time by email
    SC 13G/A 1 tv02115-unitedhealthgroupinc.htm SCHEDULE 13G/A unitedhealthgroupinc

    SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549

    Schedule 13G

    Under the Securities Exchange Act of 1934
    (Amendment No.: 7)*

    Name of issuer:  UnitedHealth Group Inc.

    Title of Class of Securities:  Common Stock

    CUSIP Number:  91324P102

    Date of Event Which Requires Filing of this Statement: December 31, 2021

    Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

    ☒ Rule 13d-1(b)

    ☐ Rule 13d-1(c)

    ☐ Rule 13d-1(d)

    *The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.

    The information required in the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

    (Continued on the following page(s))

     

     

    13G

    CUSIP No.:  91324P102

    1.  NAME OF REPORTING PERSON
    I.R.S. IDENTIFICATION NO. OF ABOVE PERSON

    The Vanguard Group - 23-1945930

    2.  CHECK THE APPROPRIATE [LINE] IF A MEMBER OF A GROUP

    A. 

    B.  X

    3.  SEC USE ONLY

    4.  CITIZENSHIP OF PLACE OF ORGANIZATION

    Pennsylvania

    (For questions 5-8, report the number of shares beneficially owned by each reporting person with:)

    5.  SOLE VOTING POWER

    0

    6.  SHARED VOTING POWER

    1,492,432

    7.  SOLE DISPOSITIVE POWER

    75,680,661

    8.  SHARED DISPOSITIVE POWER

    3,803,201

    9.  AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

    79,483,862

    10.  CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES

    N/A

    11.  PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9

    8.44%

    12.  TYPE OF REPORTING PERSON

    IA

     

     

    SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549

    Schedule 13G
    Under the Securities Act of 1934

    Item 1(a) - Name of Issuer:

    UnitedHealth Group Inc.

    Item 1(b) - Address of Issuer's Principal Executive Offices:

    United Health Group Center, 9900 Bren Road East
    Minnetonka, MN 55343

    Item 2(a) - Name of Person Filing:

    The Vanguard Group - 23-1945930

    Item 2(b) – Address of Principal Business Office or, if none, residence:

    100 Vanguard Blvd.
    Malvern, PA 19355

    Item 2(c) – Citizenship:

    Pennsylvania

    Item 2(d) - Title of Class of Securities:

    Common Stock

    Item 2(e) - CUSIP Number

    91324P102

    Item 3 - Type of Filing:

    This statement is being filed pursuant to Rule 13d-1.  An investment adviser in accordance with §240.13d-1(b)(1)(ii)(E).

    Item 4 - Ownership:

      (a) Amount Beneficially Owned:

      (b) Percent of Class:

     

     

    (c)  Number of shares as to which such person has:

    (i)  sole power to vote or direct to vote:  

    (ii)  shared power to vote or direct to vote:  

    (iii)  sole power to dispose of or to direct the disposition of:  

    (iv)  shared power to dispose or to direct the disposition of:  

    Comments:

    The responses to questions 5 through 9 and 11 on the cover page(s) are incorporated by reference into this Item 4.  

    Item 5 - Ownership of Five Percent or Less of a Class:

    If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than 5 percent of the class of securities, check the following ☐

    Item 6 - Ownership of More Than Five Percent on Behalf of Another Person:

    The Vanguard Group, Inc.'s clients, including investment companies registered under the Investment Company Act of 1940 and other managed accounts, have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, the securities reported herein.

    No one other person's interest in the securities reported herein is more than 5%.

    Item 7 - Identification and Classification of the Subsidiary Which Acquired The Security Being Reported on by the Parent Holding Company:

    Not applicable

    Item 8 - Identification and Classification of Members of Group:

    Not applicable

    Item 9 - Notice of Dissolution of Group:

    Not applicable

    Item 10 - Certification:

    By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under §240.14a-11.

    Signature

    After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

    Date:  February 9, 2022

    By /s/ Christine M. Buchanan
    Name: Christine M. Buchanan
    Title:  Principal

    Get the next $UNH alert in real time by email

    Crush Q3 2025 with the Best AI Executive Assistant

    Stay ahead of the competition with Tailforce.ai - your AI-powered business intelligence partner.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Tailforce.ai

    Recent Analyst Ratings for
    $UNH

    DatePrice TargetRatingAnalyst
    6/11/2025$312.00Outperform → Neutral
    Robert W. Baird
    5/21/2025$270.00Hold → Reduce
    HSBC Securities
    5/19/2025$308.00Buy → Hold
    TD Cowen
    5/14/2025Strong Buy → Mkt Perform
    Raymond James
    5/14/2025$350.00Buy → Neutral
    BofA Securities
    4/22/2025$490.00Buy → Hold
    HSBC Securities
    4/21/2025Buy → Hold
    Argus
    1/10/2025$595.00Hold → Buy
    HSBC Securities
    More analyst ratings

    $UNH
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • CEO, UHG Hemsley Stephen J was granted 198 shares, increasing direct ownership by 0.05% to 374,606 units (SEC Form 4)

      4 - UNITEDHEALTH GROUP INC (0000731766) (Issuer)

      7/2/25 4:09:18 PM ET
      $UNH
      Medical Specialities
      Health Care
    • Director Hooper Michele J was granted 173 shares, increasing direct ownership by 0.43% to 40,479 units (SEC Form 4)

      4 - UNITEDHEALTH GROUP INC (0000731766) (Issuer)

      7/2/25 4:09:02 PM ET
      $UNH
      Medical Specialities
      Health Care
    • Director Flynn Timothy Patrick was granted 288 shares, increasing direct ownership by 3% to 9,477 units (SEC Form 4)

      4 - UNITEDHEALTH GROUP INC (0000731766) (Issuer)

      7/2/25 4:09:10 PM ET
      $UNH
      Medical Specialities
      Health Care

    $UNH
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • AM Best Assigns Issue Credit Ratings to UnitedHealth Group Incorporated's New Senior Unsecured Notes

      AM Best has assigned Long-Term Issue Credit Ratings (Long-Term IRs) of "a" (Excellent) to UnitedHealth Group Incorporated's (UnitedHealth Group) (Minnetonka, MN) (NYSE:UNH) recently issued senior unsecured notes. (See detailed list below.) The outlook assigned to these Credit Ratings (ratings) is negative. The proceeds from UnitedHealth Group's recent $3 billion debt issuance are expected to be used for general corporate purposes, including repayment of short-term borrowings, commercial paper and/or upcoming debt maturities. As of May 31, 2025, UnitedHealth Group had approximately $12.7 billion of short-term borrowings outstanding. Financial leverage at the end of first quarter 2025 was e

      6/23/25 4:57:00 PM ET
      $UNH
      Medical Specialities
      Health Care
    • UnitedHealth Group Recommends Shareholders Reject "Mini-Tender" Offer by Tutanota

      UnitedHealth Group (NYSE:UNH) today announced that it recently became aware of an unsolicited "mini-tender" offer by Tutanota LLC (Tutanota) to purchase up to 175,000 shares of UnitedHealth Group's common stock, representing significantly less than 1% of UnitedHealth Group's common stock outstanding. The offer price of $325.00 per share is conditioned on, among other things, the closing price per share of UnitedHealth Group's common stock exceeding $325.00 per share on the last full trading day before the offer expires. This means that unless this condition is waived by Tutanota, UnitedHealth Group shareholders who tender their shares in the offer will receive a below-market price. Tutano

      6/23/25 4:00:00 PM ET
      $UNH
      Medical Specialities
      Health Care
    • AM Best Revises Outlooks to Negative for UnitedHealth Group Incorporated and Its Subsidiaries

      AM Best has revised the outlooks to negative from stable and affirmed the Long-Term Issuer Credit Ratings (Long-Term ICR) of "a" (Excellent) and the Long-Term Issue Credit Ratings (Long-Term IRs) of UnitedHealth Group Incorporated (UnitedHealth Group) (Minnetonka, MN) (NYSE:UNH). AM Best also has affirmed the Short-Term IR of UnitedHealth Group. Concurrently, AM Best has revised the outlooks to negative from stable and affirmed the Financial Strength Rating (FSR) of A+ (Superior) and the Long-Term ICRs of "aa-" (Superior) of the health and dental insurance subsidiaries of UnitedHealth Group, collectively referred to as UnitedHealthcare. (See link below for a detailed listing of the companie

      6/4/25 3:50:00 PM ET
      $UNH
      Medical Specialities
      Health Care

    $UNH
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • UnitedHealth downgraded by Robert W. Baird with a new price target

      Robert W. Baird downgraded UnitedHealth from Outperform to Neutral and set a new price target of $312.00

      6/11/25 7:46:38 AM ET
      $UNH
      Medical Specialities
      Health Care
    • UnitedHealth downgraded by HSBC Securities with a new price target

      HSBC Securities downgraded UnitedHealth from Hold to Reduce and set a new price target of $270.00

      5/21/25 8:41:18 AM ET
      $UNH
      Medical Specialities
      Health Care
    • UnitedHealth downgraded by TD Cowen with a new price target

      TD Cowen downgraded UnitedHealth from Buy to Hold and set a new price target of $308.00

      5/19/25 8:51:13 AM ET
      $UNH
      Medical Specialities
      Health Care

    $UNH
    Leadership Updates

    Live Leadership Updates

    See more
    • UnitedHealth Group Investors: Please contact the Portnoy Law Firm to recover your losses. July 7, 2025 Deadline to file Lead Plaintiff Motion.

      Investors can contact the law firm at no cost to learn more about recovering their losses LOS ANGELES, May 13, 2025 (GLOBE NEWSWIRE) --  The Portnoy Law Firm advises UnitedHealth Group ("UnitedHealth" or the "Company") (NYSE:UNH) UnitedHealth investors have until July 7, 2025 to file a lead plaintiff motion. Investors are encouraged to contact attorney Lesley F. Portnoy, by phone 310-692-8883 or email: [email protected], to discuss their legal rights, or click here to join the case. The Portnoy Law Firm can provide a complimentary case evaluation and discuss investors' options for pursuing claims to recover their losses. UnitedHealth is a health insurance and health care services pr

      5/13/25 5:59:56 PM ET
      $UNH
      Medical Specialities
      Health Care
    • Charlie Baker Joins UnitedHealth Group's Board of Directors

      UnitedHealth Group (NYSE:UNH) announced Charlie Baker, the former governor of Massachusetts and a prominent former health care executive, has been appointed to its Board of Directors, effective immediately. "Charlie Baker's leadership and deep health care experience will serve UnitedHealth Group well in its efforts to make the health system work better for everyone," said UnitedHealth Group Board Chairman Stephen J. Hemsley. "Charlie is an outstanding addition to our board given his proven track record in government and in leading businesses in the health sector, including care delivery and benefits." "UnitedHealth Group has unique capabilities to improve health care outcomes, lower cos

      11/3/23 4:00:00 PM ET
      $UNH
      Medical Specialities
      Health Care
    • DNAnexus Announces Appointment of Thomas Laur as CEO

      Proven healthcare executive brings decades of experience leading successful software, data, and services companies Richard Daly remains actively involved as a member of the Board of Directors DNAnexus Inc., the leading provider of cloud-based genomic and biomedical data management and analysis software, today announced that Thomas Laur has been appointed Chief Executive Officer and member of the company's Board of Directors, effective September 11, 2023. Mr. Laur succeeds Richard Daly, who has overseen the company's significant growth since 2013 and will remain an active advisor and a member of the Board of Directors. "It has been the greatest privilege of my life to have led the evol

      9/12/23 9:02:00 AM ET
      $UNH
      Medical Specialities
      Health Care

    $UNH
    SEC Filings

    See more
    • SEC Form 8-K filed by UnitedHealth Group Incorporated

      8-K - UNITEDHEALTH GROUP INC (0000731766) (Filer)

      6/20/25 4:44:03 PM ET
      $UNH
      Medical Specialities
      Health Care
    • SEC Form 424B5 filed by UnitedHealth Group Incorporated

      424B5 - UNITEDHEALTH GROUP INC (0000731766) (Filer)

      6/18/25 5:00:15 PM ET
      $UNH
      Medical Specialities
      Health Care
    • SEC Form FWP filed by UnitedHealth Group Incorporated

      FWP - UNITEDHEALTH GROUP INC (0000731766) (Subject)

      6/17/25 5:23:28 PM ET
      $UNH
      Medical Specialities
      Health Care

    $UNH
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • President & CFO Rex John F bought $4,999,919 worth of shares (17,175 units at $291.12), increasing direct ownership by 9% to 203,796 units (SEC Form 4)

      4 - UNITEDHEALTH GROUP INC (0000731766) (Issuer)

      5/16/25 6:11:47 PM ET
      $UNH
      Medical Specialities
      Health Care
    • CEO, UHG Hemsley Stephen J bought $25,019,019 worth of shares (86,700 units at $288.57), increasing direct ownership by 15% to 679,493 units (SEC Form 4)

      4 - UNITEDHEALTH GROUP INC (0000731766) (Issuer)

      5/16/25 6:11:45 PM ET
      $UNH
      Medical Specialities
      Health Care
    • Director Flynn Timothy Patrick bought $491,786 worth of shares (1,533 units at $320.80) (SEC Form 4)

      4 - UNITEDHEALTH GROUP INC (0000731766) (Issuer)

      5/16/25 12:28:22 PM ET
      $UNH
      Medical Specialities
      Health Care

    $UNH
    Financials

    Live finance-specific insights

    See more
    • AM Best Assigns Issue Credit Ratings to UnitedHealth Group Incorporated's New Senior Unsecured Notes

      AM Best has assigned Long-Term Issue Credit Ratings (Long-Term IRs) of "a" (Excellent) to UnitedHealth Group Incorporated's (UnitedHealth Group) (Minnetonka, MN) (NYSE:UNH) recently issued senior unsecured notes. (See detailed list below.) The outlook assigned to these Credit Ratings (ratings) is negative. The proceeds from UnitedHealth Group's recent $3 billion debt issuance are expected to be used for general corporate purposes, including repayment of short-term borrowings, commercial paper and/or upcoming debt maturities. As of May 31, 2025, UnitedHealth Group had approximately $12.7 billion of short-term borrowings outstanding. Financial leverage at the end of first quarter 2025 was e

      6/23/25 4:57:00 PM ET
      $UNH
      Medical Specialities
      Health Care
    • AM Best Revises Outlooks to Negative for UnitedHealth Group Incorporated and Its Subsidiaries

      AM Best has revised the outlooks to negative from stable and affirmed the Long-Term Issuer Credit Ratings (Long-Term ICR) of "a" (Excellent) and the Long-Term Issue Credit Ratings (Long-Term IRs) of UnitedHealth Group Incorporated (UnitedHealth Group) (Minnetonka, MN) (NYSE:UNH). AM Best also has affirmed the Short-Term IR of UnitedHealth Group. Concurrently, AM Best has revised the outlooks to negative from stable and affirmed the Financial Strength Rating (FSR) of A+ (Superior) and the Long-Term ICRs of "aa-" (Superior) of the health and dental insurance subsidiaries of UnitedHealth Group, collectively referred to as UnitedHealthcare. (See link below for a detailed listing of the companie

      6/4/25 3:50:00 PM ET
      $UNH
      Medical Specialities
      Health Care
    • UnitedHealth Group Updates on Annual Shareholder Meeting, Board Actions

      UnitedHealth Group (NYSE:UNH) provided updates on its 2025 annual shareholder meeting and actions taken by its Board of Directors. Shareholders re-elected all current directors: Charles Baker, Timothy Flynn, Paul Garcia, Kristen Gil, Stephen Hemsley, Michele Hooper, F. William McNabb III, Valerie Montgomery Rice, M.D. and John Noseworthy, M.D. Shareholders also: Approved the advisory resolution on the Company's executive compensation. Ratified Deloitte & Touche LLP as the Company's independent registered public accounting firm. Voted against the shareholder proposal requesting a shareholder vote regarding excessive golden parachutes. At its regular quarterly meeting, the Boa

      6/4/25 6:50:00 AM ET
      $UNH
      Medical Specialities
      Health Care

    $UNH
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • SEC Form SC 13G/A filed by UnitedHealth Group Incorporated (Amendment)

      SC 13G/A - UNITEDHEALTH GROUP INC (0000731766) (Subject)

      2/13/24 5:16:09 PM ET
      $UNH
      Medical Specialities
      Health Care
    • SEC Form SC 13G/A filed by UnitedHealth Group Incorporated (Amendment)

      SC 13G/A - UNITEDHEALTH GROUP INC (0000731766) (Subject)

      2/9/24 10:05:20 AM ET
      $UNH
      Medical Specialities
      Health Care
    • SEC Form SC 13G/A filed by UnitedHealth Group Incorporated (Amendment)

      SC 13G/A - UNITEDHEALTH GROUP INC (0000731766) (Subject)

      2/9/23 12:39:51 PM ET
      $UNH
      Medical Specialities
      Health Care